Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
NCT04257929 is registered in ClinicalTrials.gov with Harmony Biosciences Management, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
- Lead sponsor
- Harmony Biosciences Management, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 9, 2020
- Completion date
- January 21, 2026
- Enrollment
- 65 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.